#

Dailypharm Live Search Close
  • Virtual academic conferences consider e-booth as alternative
  • by Kim, Jung-Ju | translator Byun Kyung A | 2020-05-25 06:26:24
Revised regulation on alternative sponsorship to be set in June for fall events
Academia and industry urge for flexible option to be reflected on Fair Competition Agreement

Corporate booth participating in an offline academic conference (Source: Daily Pharm DB)
Academic conferences in Korea are going through changes as many of academic events around the world are either canceled or postponed amid COVID-19 outbreak.

 

While the medical experts predict the outbreak would not end anytime soon, a number of medical academia have either convened virtual conference or are planning on one to replace their offline conference.

 

But as the regulations related to virtual conferences are not yet specified, the government, pharmaceutical industry and the affected academic societies have decided to revise the relevant regulations.

 

On May 20, officials from the government, industry and academic societies held a press conference and announced the regulations would be amended within this month for the fall conferences to refer to.

 

According to Ministry of Health and Welfare (MOHW), the current Fair Competition Agreement only stipulates offline sponsorship of academic conference by pharmaceutical companies, which does not reflect the recent circumstances.

 

In fact, Korean Diabetes Association has already conducted an online conference, but the pharmaceutical company sponsorship was not properly managed by the relevant regulation.

 

Medical academic conferences are essential events to share the latest medical findings and to educate healthcare professionals.

 

Pharmaceutical and medical device companies make significant financial contribution to the conferences as they use the events to showcase their products in development or latest clinical outcomes through presentations by medical professionals.

 

The academic societies spend the most on labor, venue rental, food and beverage and other out-of-pocket costs, which were usually covered by the companies’ donation, advertisement fee and incidental expenses.

 

Regardless, from now on virtually formatted events would be more sought after as recently the conventional offline conferences have been restricted amid COVID-19 outbreak.

 

The shift in the format of local and international conferences would inevitably result in change in method of sponsorship.

 

The most mentioned method of sponsorship is virtually provided ‘e-booth.’ Already the pharmaceutical companies are inquiring their associated organization about the feasibility of sponsorship through e-booth and relevant method and level of contribution.

 

The Korean government and industry officials elaborated, under the code of Fair Competition Agreement set by the Fair Trade Commission, the healthcare product suppliers are supposed to receive approval on the academic conference sponsorship, but the details on online sponsorship is still ambiguous.

 

Meanwhile, MOHW, medical industry and pharmaceutical and medical device industry organization have recently established ‘Revised Academic Conference Sponsorship Standard’ to ban redundant sponsorship of providing donation and other advertisement fee and incidental expense.

 

In other words, the advertisement fee and incidental expense can be provided if the company does not give donation.

 

Medical academia “Confusion may get worse for the fall conferences without regulatory preparation” Academic societies struggling with offline conferences now fear the sluggish preparation of online event sponsorship regulation would eventually delay the fall conferences and cause turmoil.

 

Korean Society for the Study of Obesity (KOSSO), for instance, is organizing an international conference in coming September.

 

But it is now greatly challenged with inviting foreign speakers.

 

The societies urge more attentions are also needed for international conference as well.

 

KOSSO official commented with concerned voice that “The government should acknowledge the online attendance and quickly establish regulation on virtual or video conference, or even consider temporarily alleviating related regulations,” if not, “the academic societies would experience confusion with the conference management until next year.” Korean Academy of Medical Sciences is having similar concerns.

 

The academy noted, “If the COVID-19 would continue to affect fall conferences, the academic societies would experience a massive confusion,” and “the societies are even considering on opening an option of ‘double booth.’ Also, we are expecting the government to allow banner and in-stream ads spots as well as sponsored product introduction time for the virtual conference.” Pharmaceutical industry “Needs to quickly work on long-term plan,” and Government “Newly revised regulation would be available next month” Regarding the situation, the pharmaceutical industry representatives firmly stated relevant regulation should be established as soon as possible, however, they should be constructed in efficient and reasonable fashion.

 

Korea Pharmaceutical and Bio-pharma Manufacturers Association (KPBMA) official said, “We are getting endless inquires from the member companies.

 

As sponsoring the academic conference is integral in sharing the latest developments and findings to healthcare professionals, it should be provided in any form or style,” and “the organization would closely cooperate on figuring out the feasible form of alternative sponsorship and appropriate level of the sponsorship.” Korean Research-based Pharmaceutical Industry Association (KRPIA) officials also stated, “We have task force discussing the matter in-depth.

 

The organization is closely collaborating with the government to stipulate operating virtual booth and to work on other essential details through the Fair Competition Agreement,” and “We expect the discussion to efficiently build the framework for alternative sponsorship that can minimize the impact of COVID-19 on academic activities.” Accordingly, the government, medical industry and supplier organizations have recently convened a meeting and agreed on the necessity of the online conference sponsorship regulation.

 

The meeting also concluded that another meeting should be convened early next month to finalize the amendment to the regulation.

 

MOHW official said, “Based on the prospective that Post-Corona Era would prefer holding local and international conferences virtually, everyone agreed online sponsorship like ‘e-booth’ should be deliberated.” The official added, “The details would be decided in next month’s meeting.

 

The alternative sponsorship would be sorted out promptly for the fall conference to utilize.”

 

  • 0
Reader Comment
0
Member comment Write Operate Rule
Colse

댓글 운영방식은

댓글은 실명게재와 익명게재 방식이 있으며, 실명은 이름과 아이디가 노출됩니다. 익명은 필명으로 등록 가능하며, 대댓글은 익명으로 등록 가능합니다.

댓글 노출방식은

댓글 명예자문위원(팜-코니언-필기모양 아이콘)으로 위촉된 데일리팜 회원의 댓글은 ‘게시판형 보기’와 ’펼쳐보기형’ 리스트에서 항상 최상단에 노출됩니다. 새로운 댓글을 올리는 일반회원은 ‘게시판형’과 ‘펼쳐보기형’ 모두 팜코니언 회원이 쓴 댓글의 하단에 실시간 노출됩니다.

댓글의 삭제 기준은

다음의 경우 사전 통보없이 삭제하고 아이디 이용정지 또는 영구 가입제한이 될 수도 있습니다.

  • 저작권·인격권 등 타인의 권리를 침해하는 경우

    상용 프로그램의 등록과 게재, 배포를 안내하는 게시물

    타인 또는 제3자의 저작권 및 기타 권리를 침해한 내용을 담은 게시물

  • 근거 없는 비방·명예를 훼손하는 게시물

    특정 이용자 및 개인에 대한 인신 공격적인 내용의 글 및 직접적인 욕설이 사용된 경우

    특정 지역 및 종교간의 감정대립을 조장하는 내용

    사실 확인이 안된 소문을 유포 시키는 경우

    욕설과 비어, 속어를 담은 내용

    정당법 및 공직선거법, 관계 법령에 저촉되는 경우(선관위 요청 시 즉시 삭제)

    특정 지역이나 단체를 비하하는 경우

    특정인의 명예를 훼손하여 해당인이 삭제를 요청하는 경우

    특정인의 개인정보(주민등록번호, 전화, 상세주소 등)를 무단으로 게시하는 경우

    타인의 ID 혹은 닉네임을 도용하는 경우

  • 게시판 특성상 제한되는 내용

    서비스 주제와 맞지 않는 내용의 글을 게재한 경우

    동일 내용의 연속 게재 및 여러 기사에 중복 게재한 경우

    부분적으로 변경하여 반복 게재하는 경우도 포함

    제목과 관련 없는 내용의 게시물, 제목과 본문이 무관한 경우

    돈벌기 및 직·간접 상업적 목적의 내용이 포함된 게시물

    게시물 읽기 유도 등을 위해 내용과 무관한 제목을 사용한 경우

  • 수사기관 등의 공식적인 요청이 있는 경우

  • 기타사항

    각 서비스의 필요성에 따라 미리 공지한 경우

    기타 법률에 저촉되는 정보 게재를 목적으로 할 경우

    기타 원만한 운영을 위해 운영자가 필요하다고 판단되는 내용

  • 사실 관계 확인 후 삭제

    저작권자로부터 허락받지 않은 내용을 무단 게재, 복제, 배포하는 경우

    타인의 초상권을 침해하거나 개인정보를 유출하는 경우

    당사에 제공한 이용자의 정보가 허위인 경우 (타인의 ID, 비밀번호 도용 등)

  • ※이상의 내용중 일부 사항에 적용될 경우 이용약관 및 관련 법률에 의해 제재를 받으실 수도 있으며, 민·형사상 처벌을 받을 수도 있습니다.

    ※위에 명시되지 않은 내용이더라도 불법적인 내용으로 판단되거나 데일리팜 서비스에 바람직하지 않다고 판단되는 경우는 선 조치 이후 본 관리 기준을 수정 공시하겠습니다.

    ※기타 문의 사항은 데일리팜 운영자에게 연락주십시오. 메일 주소는 dailypharm@dailypharm.com입니다.

If you want to see the full article, please JOIN US (click)